Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid by DAVID CALDERÓN GUZMÁN et al.
443
Acta Pharm. 66 (2016) 443–448 Short communication
DOI: 10.1515/acph-2016-0027
Effect of cerebrolysin on dopaminergic neurodegeneration of rat 
with oxidative stress induced by 3-nitropropionic acid
The study tested the hypothesis that cerebrolysin pro-
tects the brain from free radicals in rats treated with 3-ni-
tropropionic acid (3-NPA). To address this hypothesis, 
the levels of dopamine (DA) and some oxidative stress 
biomarkers were measured after administration of 
3-NPA. Young male Fischer rats were treated for three 
days with cerebrolysin, 3-NPA or both substances. Their 
brains were extracted, and DA, lipid peroxidation (LP), 
glutathione (GSH), calcium, and H2O2 were measured 
using validated methods. In the cortex, hemispheres and 
cerebellum/medulla oblongata of the group treated with 
cerebrolysin and 3-NPA, the levels of DA and LP de-
creased. In addition, calcium and H2O2 levels decreased 
in the hemispheres of the same group, while GSH in-
creased in cortex. The increased dopamine metabolism 
due to the administration of cerebrolysin led to increased 
formation of radical species and oxidative stress, espe-
cially when free radicals were generated by 3-NPA. 
Keywords: cerebrolysin, dopamine, 3-nitropropionic acid, 
oxidative stress
 
Studies of neurological disorders suggest that excitotoxicity induces a huge increase 
in intracellular Ca2+ concentrations and an increase in the production of free radicals via 
lethal pathways (1). This damage is the primary event in 3-nitropropionic acid (3-NPA) 
toxicity, which induces neurodegeneration in female Wistar rats, and its systemic admini-
stration to rats is used as an important model of Huntington’s disease (2). Cerebrolysin is 
a drug that consists of small brain-derived peptides, which are similar or identical to those 
produced endogenously. Its content of 25 % of low-molecule peptides allows it to partially 
cross the blood-brain barrier (3). Cerebrolysin improves synaptic plasticity and behavioral 
performance and has been successfully studied in animal models, in which it was proved 
to substantially decrease oxidative stress (4), which particularly affects the central nervous 
system. However, its mechanism of action is not completely clear. The above findings sug-










1 Laboratorio de Neurociencias
Instituto Nacional de Pediatría (INP) 
México City, México
2 Laboratorio de Bacteriología Experimental
INP, México City, México
3 Laboratorio de Farmacología, INP
México City, México
Accepted March 8, 2016 
Published online May 16, 2016
* Correspondence; e-mail: juarezol@yahoo.com
444
D. C. Guzmán et al.: Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropi-
onic acid, Acta Pharm. 66 (2016) 443–448.
 
cell components, mainly plasma membrane lipids (5), the central nervous system is par-
ticularly susceptible to their effects. 
Based on the above, the purpose of the present study is to compare the protective effect 
of cerebrolysin alone with that of cerebrolysin combined with 3-nitropropionic acid on the 
levels of dopamine (DA) and of selected oxidative stress biomarkers in important brain 
regions in young rats. 
EXPERIMENTAL
Animal management and care were conducted in accordance with the international 
guidelines on animal care and Mexican Guidelines ZOO-062. Approval of the institutional 
ethical committee was obtained. 
Twenty-four young male Fischer rats (80 g, 45 days old, were deployed for the study 
and were procured from the certified Bioterium of the Metropolitan University of Mexico 
City, Mexico, with a balanced food (Rodent diet 5001) and drinking water ad libitum. The 
animals were divided into 4 groups (n = 6) and were treated as follows: control group (NaCl 
0.9 %), cerebrolysin group (2.5 g kg–1 b.m.), cerebrolysin (2.5 g kg–1 b.m.) + 3-nitropropionic 
acid group  (20 mg kg–1 b.m.) and 3-nitropropionic acid group  (20 mg kg–1 b.m.). All sub-
stances were administered intraperitoneally every 24 hours for 3 consecutive days. Thirty 
minutes after the final drug administration, the animals were sacrificed using a guillotine 
and their brains were immersed in saline solution (NaCl 0.9 %) at 4 °C.
Blood was obtained immediately after sacrifice and evaluated for glucose and hemo-
globin levels. Brain region dissections were carried out for the cortex, hemispheres, and 
cerebellum combined with the medulla oblongata. Dissected brain regions were stored in 
5 volumes of  0.05 mol L–1 Tris-HCl, pH 7.4, and evaluated for ATPase, lipid peroxidation 
and H2O2 levels. An aliquot from each region was homogenized in 0.1 mol L–1 perchloric 
acid (50:50, V/V) to evaluate the concentrations of reduced glutathione (GSH), dopamine, 
and calcium. 
Measurement of blood glucose was performed in all groups of animals at the moment 
of sacrifice in non-anticoagulant blood using  Accu-Chek Active (Roche Mannheim, Ger-
many) glucose meters (6).
The DA levels were quantified in the supernatant of tissue homogenized in HClO4 
after centrifugation at 9,000 rpm for 10 min in a microcentrifuge (Mikro 12–42, Hettich 
Zentrifugen, Germany) using the method reported by Calderon et al. (7).
GSH levels were measured in the perchloric acid supernatant of the homogenized tis-
sue, obtained after centrifuging at 9,000 rpm for 5 min using a method modified after His-
sin and Hilf (8). 
TBARS determination was performed using modified method of Gutteridge and Hal-
liwell (5). To measure calcium, the supernatant from brain homogenates of all animal 
groups was evaluated using the Ca-Color Arsenazo III AA direct colorimetric method 
produced by Wiener Laboratory (Rosario, Argentina). 
The ATPase activity was assayed according to the method proposed by Calderón-
Guzmán et al. (9). Supernatant absorbance was quantified at 660 nm  (Helios-α UNICAM 
spectrophotometer, UK).  
Determination of H2O2 was performed using a modified method from Asru (10). 
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Statistics 
Kruskal-Wallis and ANOVA tests were used with their corresponding contrasts and 
previous variance homogeneity comparison. Statistical significance was defined at p < 0.05. 
JMP Statistical Discovery software of the SAS version 8.0.0  was used.
RESULTS AND DISCUSSION
Hemoglobin level showed a non-significant decrease in animal groups treated with 
cerebrolysin plus 3-NPA or with 3-NPA alone but these groups showed a statistically sig-
nificant increase in the glucose level (p < 0.05). 
Dopamine levels in brain regions of young rats treated with cerebrolysin and 3-nitro-
propionic acid decreased significantly (p < 0.03) in the cortex (Table II), hemispheres (Table 
III) and cerebellum/medulla oblongata (Table IV)  compared to the control or cerebrolysin 
group.
In animals treated with cerebrolysin alone or cerebrolysin plus 3-NPA, lipid peroxida-
tion in the cortex decreased significantly (p < 0.02, Table II) compared to the control. In 
animals treated with cerebrolysin and 3-NPA, calcium and H2O2 levels decreased signifi-
cantly (p < 0.001) in hemisphere regions (Table III) compared with to the control group.
The GSH concentration increased in cortex regions in animals treated with cerebroly-
sin plus 3-NPA because of the production of reactive oxygen species is the primary event 
in 3-NPA toxicity (11). ATPase activity, which is dependent on calcium and magnesium, 
increased in the cortex and hemisphere regions of the animals that received cerebrolysin 
alone or in combination with 3-NPA, whereas it decreased in animals treated with 3-NPA 
alone. Increased Ca2+, Mg2+ – ATPase activity protects against substances that induce brain 
injury by inhibiting free radical production, regulating calcium-dependent processes, and 
supporting the antioxidant redox system.
DA signaling and distribution are primarily modulated by the DA transporter (DAT) 
and the vesicular monoamine transporter (VMAT)-2, which transport DA into presynaptic 
terminals and synaptic vesicles. These transporters are regulated by complex processes 
Table I. Glucose and hemoglobin in the blood of young rats treated with cerebrolysin and 3-nitropropionic acid 
Group Glucose 
(mg per 100 mL)
Hemoglobin 
(g per 100 mL)
Control (NaCl 0.9 %) 126.3 ± 2.2a 22.2 ± 4.7
Cerebrolysin 124.0 ± 4.7b 20.6 ± 3.6
Cerebrolysin + 3-NPA 149.3 ± 7.8a,b 17.2 ± 4.2
3-NPA 146.00 ± 3.0a,b 26.14 ± 3.1
Applied doses: cerebrolysin (2.5 g kg–1), 3-nitropropionic acid (3-NPA) (20 mg kg–1). 
Mean value ± SD,  n = 6.
a,b Statistically significant differences at p < 0.05.
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Table II. Dopamine levels and biomarkers of oxidative stress in the cortex regions of young rats treated with 

















Control 2.20 ± 0.93b 9.58 ± 1.6b 3.98 ± 0.13 0.12 ± 0.03 362.3 ± 98b 161.7 ± 54.0b
Cerebrolysin 3.36 ± 0.38b,c 7.84 ± 1.0b 4.09 ± 0.41 0.14 ± 0.02 332.9 ± 128c 235.2 ± 75.5b,c
Cerebrolysin 
+ 3-NPA 2.43 ± 0.51
c 7.99 ± 1.2b 4.25 ± 0.30 0.13 ± 0.03 441.05 ± 74b,c,d 244.1 ± 35.9b,d
3-NPA 2.65 ± 0.47b,c 8.05 ± 0.7b 4.30 ± 1.42 0.08 ± 0.02 214.47 ± 74b,c,d 95.9 ± 53.7b,c,d
DA – dopamine, TBARS – thiobarbituric acid reactive substances, GSH – glutathione, 3-NPA – 3-nitropropionic acid
Applied doses: cerebrolysin (2.5 g kg–1), 3-nitropropionic acid (3-NPA) (20 mg kg–1). 
Mean value ± SD,  n = 6.  
a Wet mass (tissue) basis.
b,c,d Statistically significant differences at p < 0.05 within a parameter.
Table III. Dopamine levels and biomarkers of oxidative stress in hemispheres regions of young rats treated 

















Control 3.34 ± 0.85 11.8 ± 0.9 4.13 ± 0.14b 0.20 ± 0.02b 419.8 ± 124 253.5 ± 104b
Cerebrolysin 4.27 ± 1.08b 13.05 ± 1.9 4.06 ± 0.16c 0.19 ± 0.02c 369.0 ± 126 603.8 ± 193b,c
Cerebrolysin 
+ 3-NPA 3.29 ± 0.86
b 12.04 ± 2.0 3.79 ± 0.07b,c,d 0.17 ± 0.02b,c,d 346.0 ± 57 379.4 ± 80b,c,d
3-NPA 3.88 ± 0.88 11.95 ± 2.2 4.75 ± 1.0b,c,d 0.15 ± 0.10b,c,d 296.9 ± 80 166.8 ± 46b,c,d
For symbols see Table II.
Applied doses: cerebrolysin (2.5 g kg–1), 3-nitropropionic acid (20 mg kg–1). Mean value ± SD,  n = 6. 
a Wet mass (tissue) basis.
b,c,d
 Statistically significant differences at p < 0.05 within a parameter.
such as phosphorylation and protein-protein interactions. Thus, the peptide-containing 
drug cerebrolysin may act in this complex process (12) offering a therapeutic treatment of 
DA-related disorders.
Since dopamine levels increased in the cortex and hemisphere regions of animals that 
received cerebrolysin alone, it may be assumed that cerebrolysin is a novel dopamine ago-
nist. The decrease of lipid peroxidation in the cortex regions of animals that received cere-
447
D. C. Guzmán et al.: Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropi-
onic acid, Acta Pharm. 66 (2016) 443–448.
 
brolysin coincides with the findings of Patocková et al. (13).  Besides, the increase of dopa-
mine in the same groups suggests that DA may play a significant role in regulating the 
response to oxidative stress (14).
CONCLUSIONS
The increased dopamine metabolism due to the administration of cerebrolysin led to 
increased formation of radical species and oxidative stress, especially when free radicals were 
generated by 3-NPA. However, we recommend further studies to be conducted to investigate 
the possible beneficial effect of cerebrolysin on dopamine levels in other animal models.
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